These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 32431219)
1. Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension. Gu X; Wang Y; Wang H; Wu H; Li W; Wang J; Li N J Biomol Struct Dyn; 2021 Jul; 39(11):3912-3923. PubMed ID: 32431219 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension. Dai Y; Chen X; Song X; Chen X; Ma W; Lin J; Wu H; Hu X; Zhou Y; Zhang H; Liao Y; Qiu Z; Zhou Z J Am Coll Cardiol; 2019 May; 73(20):2567-2580. PubMed ID: 31118151 [TBL] [Abstract][Full Text] [Related]
3. Understanding the molecular mechanism of endothelin ET Wang L; Wang L; Yan F Biophys J; 2022 Jul; 121(13):2490-2502. PubMed ID: 35660104 [TBL] [Abstract][Full Text] [Related]
4. Baicalein Ameliorates Pulmonary Arterial Hypertension Caused by Monocrotaline through Downregulation of ET-1 and ET Hsu WL; Lin YC; Jeng JR; Chang HY; Chou TC Am J Chin Med; 2018; 46(4):769-783. PubMed ID: 29737212 [TBL] [Abstract][Full Text] [Related]
5. Revealing the interaction modes of 5-HT2A receptor antagonists and the Structure-Based virtual screening from FDA and TCMNP database. Wang Y; Joseph J; Gao Y; Hu B; Geng X; Wu D; Wang J; Zhang F J Biomol Struct Dyn; 2021 Jul; 39(10):3681-3692. PubMed ID: 32406337 [TBL] [Abstract][Full Text] [Related]
6. Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition. Nagarajan H; Vetrivel U Life Sci; 2021 Mar; 269():119082. PubMed ID: 33482184 [TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979 [TBL] [Abstract][Full Text] [Related]
14. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents. Pan Z; Wang Y; Gu X; Wang J; Cheng M J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening. Wang X; Zhang Y; Liu Q; Ai Z; Zhang Y; Xiang Y; Qiao Y Int J Mol Sci; 2016 Mar; 17(3):389. PubMed ID: 26999111 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel serine/threonine protein phosphatase 1 inhibitors from traditional Chinese medicine through virtual screening and biological assays. Zhu Y; Gao Y; Sun X; Wang C; Rui X; Si D; Zhu J; Li W; Liu J J Biomol Struct Dyn; 2020 Nov; 38(18):5464-5473. PubMed ID: 31820681 [TBL] [Abstract][Full Text] [Related]
19. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation. Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817 [TBL] [Abstract][Full Text] [Related]
20. Quantitative structure activity relationship and molecular simulations for the exploration of natural potent VEGFR-2 inhibitors: an Sharma N; Sharma M; Rahman QI; Akhtar S; Muddassir M J Biomol Struct Dyn; 2021 May; 39(8):2806-2823. PubMed ID: 32363995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]